RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Financials
  4. Cost of revenue

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Period EndCost of revenue (Million USD)YoY (%)
Jun 30, 20252,091+3.02%
Jun 30, 20242,030+8.71%
Jun 30, 20231,867+20.18%
Jun 30, 20221,554+14.44%
Jun 30, 20211,358+9.56%
Jun 30, 20201,239+15.82%
Jun 30, 20191,070+9.40%
Jun 30, 2018978+13.07%
Jun 30, 2017865+12.01%
Jun 30, 2016772+15.69%
Jun 30, 2015668+18.11%
Jun 30, 2014565-1.50%
Jun 30, 2013574+4.75%
Jun 30, 2012548+9.16%
Jun 30, 2011502

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)